Rosenmayr-Templeton, Louise et al. published their research in Therapeutic Delivery in 2022 | CAS: 2492423-29-5

((2R,3S,4R,5R)-3,4-Dihydroxy-5-((Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate (cas: 2492423-29-5) belongs to tetrahydrofuran derivatives. THF (Tetrahydrofuran) is water-miscible and has a low viscosity making it a highly versatile solvent used in a variety of industries. THF (Tetrahydrofuran) is also used as a starting material for the synthesis of poly(tetramethylene ether) glycol (PTMG), etc.Formula: C13H19N3O7

An industry update: what’s new in the field of therapeutic delivery was written by Rosenmayr-Templeton, Louise. And the article was included in Therapeutic Delivery in 2022.Formula: C13H19N3O7 The following contents are mentioned in the article:

A review. Summary : This Industry Update provides an overview of the some of the key events in the pharmaceutical world in Dec. 2021. In this month Eli Lilly & Co invested heavily in drug discovery with deals with Regor Therapeutics on metabolic diseases, and Foghorn Therapeutics on cancer and other diseases caused by faults in the regulation of chromatin unpacking and repacking. Treatments for Covid-19 also feature heavily with the emergency authorization of molnupiravir and Paxlovid in the USA, and BiondVax’s collaboration agreement with Max Planck and the University Medical Center, Goettingham on their alpaca-based single-chain antibodies targeting the SARS-CoV-2 spike protein. Lastly, this month brought good news on several diseases with poor prognosis and no or limited treatment options. This included Novartis’s acquisition of Gyroscope and its gene therapy for age-related macular degeneration, Merck’s purchase of Chord Therapeutics and the rights of develop cladribine for generalized myasthenia gravis and neuromyelitis optica spectrum disorders, pos. phase III interim results for UCB’s, Bimzelx, in ankylosing spondylitis and AstraZeneca and Ionis co-development and commercialization deal on eplontersen for transthyretin amyloidosis. This study involved multiple reactions and reactants, such as ((2R,3S,4R,5R)-3,4-Dihydroxy-5-((Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate (cas: 2492423-29-5Formula: C13H19N3O7).

((2R,3S,4R,5R)-3,4-Dihydroxy-5-((Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate (cas: 2492423-29-5) belongs to tetrahydrofuran derivatives. THF (Tetrahydrofuran) is water-miscible and has a low viscosity making it a highly versatile solvent used in a variety of industries. THF (Tetrahydrofuran) is also used as a starting material for the synthesis of poly(tetramethylene ether) glycol (PTMG), etc.Formula: C13H19N3O7

Referemce:
Tetrahydrofuran – Wikipedia,
Tetrahydrofuran | (CH2)3CH2O – PubChem